SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-24-011822
Filing Date
2024-08-07
Accepted
2024-08-07 07:26:24
Documents
15
Period of Report
2024-08-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp216241_8k.htm   iXBRL 8-K 23106
2 EXHIBIT 99.1 dp216242_ex9901.htm EX-99.1 16719
6 GRAPHIC image_001.jpg GRAPHIC 5593
  Complete submission text file 0000950103-24-011822.txt   225380

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE anip-20240807.xsd EX-101.SCH 3045
4 XBRL LABEL FILE anip-20240807_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE anip-20240807_pre.xml EX-101.PRE 22379
18 EXTRACTED XBRL INSTANCE DOCUMENT dp216241_8k_htm.xml XML 3541
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 241181444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)